Psoriasiform eruptions during anti-TNF-α treatment: Psoriasis or not? [5]

Archives of Dermatology

Volumn 143, Issue 12, 2007, Pages 1593-1595

  Seneschal, Julien ^b   Lepreux, Sébastien ^b   Milpied, Brigitte ^b   Schaeverbeke, Thierry ^b   Taïeb, Alain ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MALE; PATCH TEST; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SKIN BIOPSY;

ADULT; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37249030025     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.12.1593     Document Type: Letter

References (6)

1. de Gannes GC, Ghoreishi M, Pope J, et al. Psoriasis and pustular dermatitis triggered by TNF-α inhibitors in patients with rheumatologic conditions. Arch Dermatol. 2007;143(2):223-231.
2. Verea MM, Del Pozo J, Yebra-Pimentel MT, et al. Psoriasiform eruption induced by infliximab. Ann Pharmacother. 2004;38(1):54-57.
3. Seneschal J, Lepreux S, Bouyssou-Gauthier ML, et al. Psoriasiform drug eruptions under anti-TNF treatment of arthritis are not true psoriasis. Acta Derm Venereol. 2007;87(1):77-80.
4. Barbaud A, Goncalo M, Bruynzeel D, et al. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis. 2001;45(6):321-328.
5. Reitamo S, Lauerma AI, Stubb S, et al. Delayed hypersensitivity to topical corticosteroids. J Am Acad Dermatol. 1986;14(4):582-589.
6. Wenzel J, Scheler M, Proelss J, et al. Type I interferon-associated cytotoxic inflammation in lichen planus. J Cutan Pathol. 2006;33(10):672-678.